These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 24931005)

  • 1. GSK-3 as potential target for therapeutic intervention in cancer.
    McCubrey JA; Steelman LS; Bertrand FE; Davis NM; Sokolosky M; Abrams SL; Montalto G; D'Assoro AB; Libra M; Nicoletti F; Maestro R; Basecke J; Rakus D; Gizak A; Demidenko ZN; Cocco L; Martelli AM; Cervello M
    Oncotarget; 2014 May; 5(10):2881-911. PubMed ID: 24931005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.
    McCubrey JA; Rakus D; Gizak A; Steelman LS; Abrams SL; Lertpiriyapong K; Fitzgerald TL; Yang LV; Montalto G; Cervello M; Libra M; Nicoletti F; Scalisi A; Torino F; Fenga C; Neri LM; Marmiroli S; Cocco L; Martelli AM
    Biochim Biophys Acta; 2016 Dec; 1863(12):2942-2976. PubMed ID: 27612668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.
    McCubrey JA; Steelman LS; Bertrand FE; Davis NM; Abrams SL; Montalto G; D'Assoro AB; Libra M; Nicoletti F; Maestro R; Basecke J; Cocco L; Cervello M; Martelli AM
    Leukemia; 2014 Jan; 28(1):15-33. PubMed ID: 23778311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer.
    Nagini S; Sophia J; Mishra R
    Semin Cancer Biol; 2019 Jun; 56():25-36. PubMed ID: 29309927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase 3: a key regulator of cellular fate.
    Forde JE; Dale TC
    Cell Mol Life Sci; 2007 Aug; 64(15):1930-44. PubMed ID: 17530463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting GSK3 and Associated Signaling Pathways Involved in Cancer.
    Duda P; Akula SM; Abrams SL; Steelman LS; Martelli AM; Cocco L; Ratti S; Candido S; Libra M; Montalto G; Cervello M; Gizak A; Rakus D; McCubrey JA
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cross-talk of NOTCH and GSK-3 signaling in colon and other cancers.
    Bertrand FE
    Biochim Biophys Acta Mol Cell Res; 2020 Sep; 1867(9):118738. PubMed ID: 32389646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells.
    McCubrey JA; Fitzgerald TL; Yang LV; Lertpiriyapong K; Steelman LS; Abrams SL; Montalto G; Cervello M; Neri LM; Cocco L; Martelli AM; Laidler P; Dulińska-Litewka J; Rakus D; Gizak A; Nicoletti F; Falzone L; Candido S; Libra M
    Oncotarget; 2017 Feb; 8(8):14221-14250. PubMed ID: 27999207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cells.
    Duda P; Akula SM; Abrams SL; Steelman LS; Gizak A; Rakus D; McCubrey JA
    Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118770. PubMed ID: 32524999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma.
    Cervello M; Augello G; Cusimano A; Emma MR; Balasus D; Azzolina A; McCubrey JA; Montalto G
    Adv Biol Regul; 2017 Aug; 65():59-76. PubMed ID: 28619606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.
    Ryu YK; Lee YS; Lee GH; Song KS; Kim YS; Moon EY
    Int J Cancer; 2012 Nov; 131(9):2067-77. PubMed ID: 22328534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells.
    Sokolosky M; Chappell WH; Stadelman K; Abrams SL; Davis NM; Steelman LS; McCubrey JA
    Cell Cycle; 2014; 13(5):820-33. PubMed ID: 24407515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta.
    Li J; Mizukami Y; Zhang X; Jo WS; Chung DC
    Gastroenterology; 2005 Jun; 128(7):1907-18. PubMed ID: 15940626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AICAR positively regulate glycogen synthase activity and LDL receptor expression through Raf-1/MEK/p42/44MAPK/p90RSK/GSK-3 signaling cascade.
    Wang HM; Mehta S; Bansode R; Huang W; Mehta KD
    Biochem Pharmacol; 2008 Jan; 75(2):457-67. PubMed ID: 17945190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells.
    Fitzgerald TL; Lertpiriyapong K; Cocco L; Martelli AM; Libra M; Candido S; Montalto G; Cervello M; Steelman L; Abrams SL; McCubrey JA
    Adv Biol Regul; 2015 Sep; 59():65-81. PubMed ID: 26257206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3 as a key regulator of cognitive function.
    Fan X; Zhao Z; Wang D; Xiao J
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):219-230. PubMed ID: 32147679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activator or inhibitor? GSK-3 as a new drug target.
    Takahashi-Yanaga F
    Biochem Pharmacol; 2013 Jul; 86(2):191-9. PubMed ID: 23643839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glycogen synthase kinase-3.
    Ougolkov AV; Billadeau DD
    Methods Mol Biol; 2008; 468():67-75. PubMed ID: 19099246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases.
    Wang C; Cui Y; Xu T; Zhou Y; Yang R; Wang T
    Biochem Pharmacol; 2023 Dec; 218():115923. PubMed ID: 37981175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.